Simple predictive models identify patients with COVID-19 pneumonia and poor prognosis

PLoS One. 2020 Dec 28;15(12):e0244627. doi: 10.1371/journal.pone.0244627. eCollection 2020.

Abstract

Background and aims: Identification of SARS-CoV-2-infected patients at high-risk of poor prognosis is crucial. We aimed to establish predictive models for COVID-19 pneumonia severity in hospitalized patients.

Methods: Retrospective study of 430 patients admitted in Vall d'Hebron Hospital (Barcelona) between 03-12-2020 and 04-28-2020 due to COVID-19 pneumonia. Two models to identify the patients who required high-flow-oxygen-support were generated, one using baseline data and another with also follow-up analytical results. Calibration was performed by a 1000-bootstrap replication model.

Results: 249 were male, mean age 57.9 years. Overall, 135 (31.4%) required high-flow-oxygen-support. The baseline predictive model showed a ROC of 0.800 based on: SpO2/FiO2 (adjusted Hazard Ratio-aHR = 8), chest x-ray (aHR = 4), prior immunosuppressive therapy (aHR = 4), obesity (aHR = 2), IL-6 (aHR = 2), platelets (aHR = 0.5). The cut-off of 11 presented a specificity of 94.8%. The second model included changes on the analytical parameters: ferritin (aHR = 7.5 if ≥200ng/mL) and IL-6 (aHR = 18 if ≥64pg/mL) plus chest x-ray (aHR = 2) showing a ROC of 0.877. The cut-off of 12 exhibited a negative predictive value of 92%.

Conclusions: SpO2/FiO2 and chest x-ray on admission or changes on inflammatory parameters as IL-6 and ferritin allow us early identification of COVID-19 patients at risk of high-flow-oxygen-support that may benefit from a more intensive disease management.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 / diagnosis*
  • COVID-19 / pathology*
  • Female
  • Hospitalization
  • Humans
  • Male
  • Middle Aged
  • Pneumonia / diagnosis*
  • Pneumonia / pathology*
  • Prognosis
  • Proportional Hazards Models
  • Retrospective Studies
  • SARS-CoV-2 / pathogenicity
  • Severity of Illness Index

Grants and funding

This work was supported in part by grant PI20/00416 from the Instituto de Salud Carlos III and was co-financed by the European Regional Development Fund (ERDF). Principal investigator: Ricardo Pujol-Borrell The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.